about
Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy.Cardiac involvement in hereditary-transthyretin related amyloidosis.Nuclear imaging for cardiac amyloidosis.Cardiac amyloidosis: the great pretender.Long-term prognostic role of cerebrovascular disease and peripheral arterial disease across the spectrum of acute coronary syndromes.Acute heart failure in patients with acute aortic syndrome: pathophysiology and clinical-prognostic implications.Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis.Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective.Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis.Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention.Isolated aortic root dilation in homocystinuria.The complex interplay between systolic and diastolic function at rest and during exercise in heart failure: the case of cardiac amyloidosis.Extracardiac imaging in amyloidosis: A long and winding (but possible) road.Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths.Histological and Histometric Characterization of Myocardial Fibrosis in End-Stage Hypertrophic Cardiomyopathy: A Clinical-Pathological Study of 30 Explanted Hearts.Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT?Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis.An unusual case of a congenital aorto-left atrial tunnel.Broadening the Phenotypic Spectrum and the Diagnostic Needs of TTR-Related Cardiac Amyloidosis.Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failureLong-term Follow up of Patients with Acute Aortic Syndromes: Relevance of both Aortic and Non-aortic EventsRedefining the histopathologic profile of acute aortic syndromes: Clinical and prognostic implicationsEtiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathyRole of ¹⁸F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective studyRole of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosisSignificance of magnetic resonance imaging in apical hypertrophic cardiomyopathyPrognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathyCoexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac AmyloidosisIdentification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD ScintigraphyThe complex interplay between fitness, genetics, lifestyle, and inflammation in the pathogenesis of coronary atherosclerosis: lessons from the Amazon rainforestWhat is the acceptable rate of false positives for STEMI within a primary PCI network? Insights from a metropolitan system with direct ambulance-based accessThe Authors ReplyPrevalence of TTR variants detected by whole-exome sequencing in hypertrophic cardiomyopathyThe complex interplay among atherosclerosis, inflammation, and degeneration in ascending thoracic aortic aneurysmsDifferences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onsetMortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European PopulationTafamidis for the treatment of transthyretin amyloidosisDiagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis
P50
Q33167286-16BC0D29-F27E-48D0-9C82-6DE08980D609Q38001756-D817A4FA-5B25-4B71-A31E-97A61A7C1B39Q38271439-8CCD018D-CFD9-4BC3-AF1A-1243821B3300Q38372860-CF977A97-7E68-4597-B72B-DD48E5413516Q40183721-645DFF18-56DB-4900-A1FB-EA9640879646Q40691820-44FA3A5F-54E8-4B4C-B86C-CA0444DBC67CQ40855969-FD6A0ACD-508D-40AB-B3B4-D5F37114F3C6Q41724575-82114E3B-50D6-40CC-85C8-933C4E1F6DC3Q43598098-FE9B2C2E-4A2F-4A20-B694-507A743F95C2Q43984985-14807C0A-ECBB-45EC-ACE2-899458D9AA1EQ48313480-7F605564-D1D0-4BD5-A4FC-B274EFC7936EQ49589041-5E9F372D-80D3-4FCA-B1AA-F361AE1CEE70Q50109252-77F5AC04-8E98-401D-AAB2-89128EAA2B4CQ50179175-F5CA995D-3604-4379-A86C-CD7D59100C43Q50212765-14EB9B06-0420-4655-AC14-37A64A667856Q52928285-B4624FA9-D83B-4DE7-B62C-1484EDB7F5B5Q52984337-43F0FC19-A841-4FBD-B437-C22103A79CE0Q53772437-3E048134-688E-4950-9A47-2232CC2FA72DQ53817461-03B5593F-D188-412B-A207-652353632B30Q54363480-70920D39-1D88-429C-ADF9-C5E6EB613CFAQ56349722-F13DFE6D-6634-45B8-9FC3-0F32691D05FEQ56353771-8110AD1B-D95C-4E01-BA3B-CD9854B9245FQ56384644-682AA53D-A6D2-4756-AAF8-4D2B923BE245Q56970128-6CCD93B2-3E54-4DE0-8BAF-E051F8136C97Q56973389-07E72D43-3810-47D9-88B5-D09795B351A3Q56985661-BF477E52-898B-465F-9F67-1DA99E2A7035Q56988424-7353DF17-DDAA-4D60-A886-B9FB2A68F7D5Q56989628-240BB375-A623-4411-8728-FC917BAFEF96Q62083154-A761242C-5471-44AD-A651-C9DAB78AFC6FQ62083156-9E0929CB-2314-4FA1-A617-A8805C7FC955Q64101742-F4A019DC-8EDF-4D4E-B339-B5FD663634B8Q82764045-09FB439F-BDF3-403E-A028-FD951E80F36DQ89210630-405B55AA-F804-49BD-9658-9274727195C3Q90285372-E9CCE95B-027D-4EE3-9BD6-A2A03CFA3CA9Q91208803-9DCA908E-0489-45B1-8A1F-5A6B9AC1115EQ91342663-89F50415-DB06-44F0-B039-6C1F8B9C189EQ91486786-C58E183A-1F1E-4597-AA11-E57076689C4EQ91611175-CE9549C7-E4EE-476B-B627-3C2C261B4475Q93121211-2D0B491D-7E19-4708-B8D7-D05C161EA90A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Massimiliano Lorenzini
@en
Massimiliano Lorenzini
@nl
type
label
Massimiliano Lorenzini
@en
Massimiliano Lorenzini
@nl
prefLabel
Massimiliano Lorenzini
@en
Massimiliano Lorenzini
@nl
P31
P496
0000-0002-1831-7853